WILLOW BIOSCIENCES INC (WLLW.CA)

CA97111B4047 - Common Stock

0.06  +0 (+9.09%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
130K
1,200.00%		820K
530.77%		1.172M
42.93%
EBITDA
YoY % growth
-19.98M
19.01%		-15.75M
21.17%		-11.646M
26.06%
EBIT
YoY % growth
-23.17M
16.80%		-18.4M
20.59%		-13.477M
26.76%
Operating Margin
-17,823.08%-2,243.90%-1,149.91%
EPS
YoY % growth
N/AN/AN/A

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
100.00%		0.00%
Q4 2021
Q2Q % growth
74.18%		-0.04%
Q4 2020
Q2Q % growth
79.25%		-0.16%
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 1.703M
154.18%		%
Q2 2024
Q2Q % growth		 1.026M
632.86%		%
Q1 2024
Q2Q % growth		 51K
-81.11%		%
Q4 2023
Q2Q % growth		 89K
-82.55%		%
Q3 2023
Q2Q % growth		 670K
1,240.00%		%
Q2 2023
Q2Q % growth		 140K
-46.15%		%
Q4 2022
Q2Q % growth		 510K
5,000.00%		22.814M-22.304M-97.76%
Q2 2022
Q2Q % growth		 260K
116.67%		%
Q1 2022
Q2Q % growth
-100.00%		%
Q4 2021
Q2Q % growth		 10K 1.008M-998.199K-99.01%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A